{
 "drug": "Heparin Sodium Injection",
 "asOf": "2026-08-25",
 "status": "in-shortage",
 "since": "11/14/2017",
 "dayN": 3206,
 "cat": "Hematology",
 "companies": [
  "Hospira, Inc., a Pfizer Company",
  "Fresenius Kabi USA, LLC",
  "B. Braun Medical Inc.",
  "Baxter Healthcare"
 ],
 "reasons": [],
 "records": [
  {
   "presentation": "Heparin Sodium, Injection, 2,000 Units/1,000 mL (2 Units/mL) (NDC 0409-7620-59)",
   "update_type": "Reverified",
   "initial_posting_date": "11/14/2017",
   "package_ndc": "0409-7620-59",
   "generic_name": "Heparin Sodium Injection",
   "company_name": "Hospira, Inc., a Pfizer Company",
   "contact_info": "844-646-4398",
   "availability": "Available",
   "update_date": "08/07/2026",
   "therapeutic_category": [
    "Hematology"
   ],
   "status": "Current",
   "dosage_form": "Injection"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "11/14/2017",
   "package_ndc": "63323-519-77",
   "generic_name": "Heparin Sodium Injection",
   "contact_info": "888-386-1300",
   "availability": "Available",
   "related_info": "Check wholesalers for inventory",
   "openfda": {
    "application_number": [
     "ANDA212441"
    ],
    "brand_name": [
     "HEPARIN SODIUM"
    ],
    "generic_name": [
     "HEPARIN SODIUM"
    ],
    "manufacturer_name": [
     "Fresenius Kabi USA, LLC"
    ],
    "product_ndc": [
     "63323-519"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "HEPARIN SODIUM"
    ],
    "rxcui": [
     "1658690",
     "1658692"
    ],
    "spl_id": [
     "3bbbe74a-1246-41a6-9fc3-ca0230529b40"
    ],
    "spl_set_id": [
     "25b0ba06-3274-4a3f-8c39-42d13764ecdf"
    ],
    "package_ndc": [
     "63323-519-02",
     "63323-519-77",
     "63323-519-01",
     "63323-519-10"
    ],
    "unii": [
     "ZZ45AB24CA"
    ]
   },
   "update_date": "08/04/2026",
   "therapeutic_category": [
    "Hematology"
   ],
   "dosage_form": "Injection",
   "presentation": "Heparin Sodium, Injection, 200 [USP'U]/100 mL (NDC 63323-519-77)",
   "company_name": "Fresenius Kabi USA, LLC",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "11/14/2017",
   "package_ndc": "0264-9872-10",
   "generic_name": "Heparin Sodium Injection",
   "contact_info": "800-227-2862",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "NDA019953"
    ],
    "brand_name": [
     "HEPARIN SODIUM IN SODIUM CHLORIDE"
    ],
    "generic_name": [
     "HEPARIN SODIUM IN SODIUM CHLORIDE"
    ],
    "manufacturer_name": [
     "B. Braun Medical Inc."
    ],
    "product_ndc": [
     "0264-9872"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "HEPARIN SODIUM"
    ],
    "rxcui": [
     "1658690",
     "1658692"
    ],
    "spl_id": [
     "48e17807-e73d-4ea2-81bc-901355903aa7"
    ],
    "spl_set_id": [
     "a3041c04-0ea8-4d36-81ce-c5091c906316"
    ],
    "package_ndc": [
     "0264-9872-10",
     "0264-9872-00"
    ],
    "unii": [
     "ZZ45AB24CA"
    ]
   },
   "update_date": "08/07/2026",
   "therapeutic_category": [
    "Hematology"
   ],
   "dosage_form": "Injection",
   "presentation": "Heparin Sodium 1,000 Units In Sodium Chloride 0.9% In Plastic Container, Injection, 200 [USP'U]/100 mL (NDC 0264-9872-10)",
   "company_name": "B. Braun Medical Inc.",
   "status": "Current"
  },
  {
   "update_type": "Revised",
   "initial_posting_date": "11/14/2017",
   "package_ndc": "63323-519-10",
   "generic_name": "Heparin Sodium Injection",
   "contact_info": "888-386-1300",
   "availability": "Available",
   "related_info": "Check wholesalers for inventory",
   "openfda": {
    "application_number": [
     "ANDA212441"
    ],
    "brand_name": [
     "HEPARIN SODIUM"
    ],
    "generic_name": [
     "HEPARIN SODIUM"
    ],
    "manufacturer_name": [
     "Fresenius Kabi USA, LLC"
    ],
    "product_ndc": [
     "63323-519"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "HEPARIN SODIUM"
    ],
    "rxcui": [
     "1658690",
     "1658692"
    ],
    "spl_id": [
     "3bbbe74a-1246-41a6-9fc3-ca0230529b40"
    ],
    "spl_set_id": [
     "25b0ba06-3274-4a3f-8c39-42d13764ecdf"
    ],
    "package_ndc": [
     "63323-519-02",
     "63323-519-77",
     "63323-519-01",
     "63323-519-10"
    ],
    "unii": [
     "ZZ45AB24CA"
    ]
   },
   "update_date": "08/04/2026",
   "therapeutic_category": [
    "Hematology"
   ],
   "dosage_form": "Injection",
   "presentation": "Heparin Sodium, Injection, 200 [USP'U]/100 mL (NDC 63323-519-10)",
   "company_name": "Fresenius Kabi USA, LLC",
   "status": "Current"
  },
  {
   "update_type": "Revised",
   "initial_posting_date": "11/14/2017",
   "package_ndc": "0264-9872-00",
   "generic_name": "Heparin Sodium Injection",
   "contact_info": "800-227-2862",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "NDA019953"
    ],
    "brand_name": [
     "HEPARIN SODIUM IN SODIUM CHLORIDE"
    ],
    "generic_name": [
     "HEPARIN SODIUM IN SODIUM CHLORIDE"
    ],
    "manufacturer_name": [
     "B. Braun Medical Inc."
    ],
    "product_ndc": [
     "0264-9872"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "HEPARIN SODIUM"
    ],
    "rxcui": [
     "1658690",
     "1658692"
    ],
    "spl_id": [
     "48e17807-e73d-4ea2-81bc-901355903aa7"
    ],
    "spl_set_id": [
     "a3041c04-0ea8-4d36-81ce-c5091c906316"
    ],
    "package_ndc": [
     "0264-9872-10",
     "0264-9872-00"
    ],
    "unii": [
     "ZZ45AB24CA"
    ]
   },
   "update_date": "08/07/2026",
   "therapeutic_category": [
    "Hematology"
   ],
   "dosage_form": "Injection",
   "presentation": "Heparin Sodium 2,000 Units in Sodium Chloride 0.9% in Plastic Container, Injection, 200 [USP'U]/100 mL (NDC 0264-9872-00)",
   "company_name": "B. Braun Medical Inc.",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "11/14/2017",
   "package_ndc": "0338-0433-04",
   "generic_name": "Heparin Sodium Injection",
   "contact_info": "888-229-0001",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "NDA018609"
    ],
    "brand_name": [
     "HEPARIN SODIUM IN SODIUM CHLORIDE"
    ],
    "generic_name": [
     "HEPARIN SODIUM"
    ],
    "manufacturer_name": [
     "Baxter Healthcare Corporation"
    ],
    "product_ndc": [
     "0338-0433",
     "0338-0431",
     "0338-0424",
     "0338-0428"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "HEPARIN SODIUM"
    ],
    "rxcui": [
     "1658690",
     "1658692"
    ],
    "spl_id": [
     "d28ff87a-c535-49db-ba0c-48080149936b"
    ],
    "spl_set_id": [
     "0d929726-76c3-48fc-b4e7-fd06409f9fb3"
    ],
    "package_ndc": [
     "0338-0431-03",
     "0338-0433-04",
     "0338-0424-18",
     "0338-0428-12"
    ],
    "unii": [
     "ZZ45AB24CA"
    ]
   },
   "update_date": "08/17/2026",
   "therapeutic_category": [
    "Hematology"
   ],
   "dosage_form": "Injection",
   "presentation": "Heparin Sodium In Sodium Chloride, Injection, 200 [USP'U]/100 mL (NDC 0338-0433-04)",
   "company_name": "Baxter Healthcare",
   "status": "Current"
  },
  {
   "presentation": "Heparin Sodium, Injection, 1,000 Units/500 mL (2 Units/mL) (NDC 0409-7620-03)",
   "update_type": "Reverified",
   "initial_posting_date": "11/14/2017",
   "package_ndc": "0409-7620-03",
   "generic_name": "Heparin Sodium Injection",
   "company_name": "Hospira, Inc., a Pfizer Company",
   "contact_info": "844-646-4398",
   "availability": "Available",
   "update_date": "08/07/2026",
   "therapeutic_category": [
    "Hematology"
   ],
   "status": "Current",
   "dosage_form": "Injection"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "11/14/2017",
   "package_ndc": "0338-0431-03",
   "generic_name": "Heparin Sodium Injection",
   "contact_info": "888-229-0001",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "NDA018609"
    ],
    "brand_name": [
     "HEPARIN SODIUM IN SODIUM CHLORIDE"
    ],
    "generic_name": [
     "HEPARIN SODIUM"
    ],
    "manufacturer_name": [
     "Baxter Healthcare Corporation"
    ],
    "product_ndc": [
     "0338-0431",
     "0338-0433",
     "0338-0424",
     "0338-0428"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "HEPARIN SODIUM"
    ],
    "rxcui": [
     "1658690",
     "1658692"
    ],
    "spl_id": [
     "d28ff87a-c535-49db-ba0c-48080149936b"
    ],
    "spl_set_id": [
     "0d929726-76c3-48fc-b4e7-fd06409f9fb3"
    ],
    "package_ndc": [
     "0338-0431-03",
     "0338-0433-04",
     "0338-0424-18",
     "0338-0428-12"
    ],
    "unii": [
     "ZZ45AB24CA"
    ]
   },
   "update_date": "08/17/2026",
   "therapeutic_category": [
    "Hematology"
   ],
   "dosage_form": "Injection",
   "presentation": "Heparin Sodium In Sodium Chloride, Injection, 200 [USP'U]/100 mL (NDC 0338-0431-03)",
   "company_name": "Baxter Healthcare",
   "status": "Current"
  }
 ]
}